The episode opens by highlighting two major events: Purdue Pharma's bankruptcy reorganization plan hearing and the start of R. Kelly's trial. Purdue Pharma, maker of OxyContin, faces a Thursday hearing where a judge will consider approving its $10 billion settlement to resolve over 3,000 opioid lawsuits. The plan, backed by creditors, includes shielding the Sackler family from future lawsuits, which has drawn opposition. On Monday, jury selection begins in Brooklyn Federal Court for singer R. Kelly, who is charged with racketeering, sexual abuse, and bribery. Prosecutors allege he ran a criminal scheme recruiting women and underage girls for sexual activity, with separate charges in Illinois and Minnesota. Also on Monday, the Ninth Circuit hears arguments on overturning class certification in a consumer lawsuit against former Theranos executive Ramesh Balwani and Walgreens Boots. Consumers bought Theranos blood testing kits from Walgreens, claiming the tests were inaccurate. The episode notes Theranos' issues with inaccurate results. On Wednesday, the Ninth Circuit has another case involving United Behavioral Health, which seeks to overturn a district court ruling that it unreasonably denied mental health and substance abuse coverage. The insurer is required to reprocess 67,000 claims. The episode concludes with a summary, emphasizing its role as a weekly preview for the legal community. The format is concise, covering multiple cases in a news-style delivery without deep analysis. Recurring themes include corporate liability, consumer fraud, and criminal justice. Key moments include the specifics of the Purdue settlement and R. Kelly's charges, providing actionable insights for listeners.
